$PKI News

Last published 2y ago

2y agoAVTR NXPI STT PKIStar Mountain Capital adds former Carlyle Vice Chairman of Global Buyout & Operating Committee Member, Gregory Summe, as Senior AdvisorBusiness WireStar Mountain Capital, a rapidly growing employee-owned specialized investment firm with over $3.5 billion AUM, focused on delivering systematic alpha and low market correlated returns from high yielding private loans
3y agoPKIRevvity Inc. (PKI) Q1 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoPKIRevvity Announces Financial Results for the First Quarter of 2023Business WireRevenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes
3y agoPKILaunching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to CureBusiness WireTransformation aimed at revolutionizing next generation scientific breakthroughs that solve the world's greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete,
3y agoARES PKIAres Management Corporation Announces U.S. Direct Lending Origination Activity for the First Quarter and Last Twelve Months 2023Business WireApproximately $2.1 Billion in New Commitments Closed in the First Quarter and Approximately $23.5 Billion closed in the Last Twelve Months Ended March 31, 2023 Ares Management Corporation announced today that funds
3y agoPKIPerkinElmer Board Declares Quarterly DividendBusiness WireThe Board of Directors of PerkinElmer, Inc. (NYSE:PKI) today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 11, 2023 to all shareholders of record at the
3y agoPKIPerkinElmer to Hold Earnings Call on Thursday, May 11, 2023Business WirePerkinElmer Inc. (NYSE:PKI), today announced that it will release its first quarter 2023 financial results prior to market open on Thursday, May 11, 2023. The Company will host a conference call the same day at 8:00
3y agoPKIParkland Corporation Announces First Quarter 2023 DividendPR NewswireCALGARY, AB, March 13, 2023 /PRNewswire/ - Parkland Corporation ("Parkland") (TSX:PKI) announces that a dividend of $0.34 per share will be paid on April 14, 2023 to shareholders of record on March 22, 2023. The
3y agoPKIPerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services BusinessesBusiness WireTransforms into new Life Sciences and Diagnostics company PerkinElmer Inc. (NYSE:PKI), today announced that it has successfully completed the previously announced divestiture of its Applied, Food and Enterprise
3y agoPKIPerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor ForumBusiness WirePerkinElmer Inc., (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor
3y agoPKIPerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery WorkflowsBusiness WireCompany will showcase ultrasensitive platform for high-throughput screening applications at SLAS2023 alongside its newest NGS liquid handler while highlighting other workflow innovations PerkinElmer, Inc., (NYSE:PKI),
3y agoPKIPerkinElmer to Present at Upcoming Investor ConferencesBusiness WirePerkinElmer Inc., (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 43rd Annual Health Care Conference and the Barclays Global
3y agoPKIPerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022Business WireFourth quarter revenue from continuing operations of $741 million; (28)% reported growth; (23)% organic growth; 8% non-COVID organic growth Combined* total fourth quarter revenue of $1,089 million; 8% combined
3y agoPKIPerkinElmer Board Declares Quarterly DividendBusiness WireThe Board of Directors of PerkinElmer, Inc. (NYSE:PKI) today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on May 12, 2023 to all shareholders of record at the close
3y agoAPH PKIPrahlad Singh Appointed to Board of Directors of Amphenol CorporationBusiness WireAmphenol Corporation (NYSE:APH) today announced that Prahlad Singh, PhD has been appointed to Amphenol's board of directors. With his appointment, the size of the company's board has increased to 10 members. Dr. Singh
3y agoPKIPerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter OutlookBusiness WirePerkinElmer Inc., (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that it will release its fourth quarter and full year 2022 financial results prior to market open on Tuesday,
3y agoPKIPerkinElmer to Present at J.P. Morgan Healthcare ConferenceBusiness WirePerkinElmer Inc., (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at
3y agoPKIPerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector AssaysBusiness WireStreamlined workflows aim to shorten research and development for novel therapies to combat diseases like cancer and Alzheimer's PerkinElmer, Inc., (NYSE:PKI), a global leader committed to innovating for a
3y agoPKIPerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in NewbornsBusiness WireBuilding on its contributions to newborn screening globally, PerkinElmer's latest FDA authorized assay enables the simultaneous detection of SMA and SCID PerkinElmer Inc. (NYSE:PKI), a global leader committed to
4y agoPKIPerkinElmer to Present at 2022 Stifel Healthcare ConferenceBusiness WirePerkinElmer Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2022 Stifel Healthcare Conference on Wednesday, November 16, 2022 at 9:10
4y agoPKIPerkinElmer Announces Financial Results for the Third Quarter of 2022Business WireThird quarter revenue of $712 million; (17)% reported growth Pro forma* total revenue of $1,033 million; 9% pro forma non-COVID organic growth Third quarter GAAP EPS from continuing operations of $0.55; pro
4y agoPKIPerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG ReportBusiness WireHighlights include increasing commitment to further reduce Scope 1 & 2 emissions and becoming a signatory of the United Nations Global Compact PerkinElmer Inc. (NYSE:PKI), a global leader committed to innovating
4y agoPKIEPIC SCIENCES EXPANDS EXECUTIVE TEAM AND WELCOMES NEW CHIEF FINANCIAL OFFICER IN PREPARATION FOR RAPID GROWTHPR NewswireBill Kullback Brings Proven Track Record of Scaling Companies for Successful Outcomes SAN DIEGO, Nov. 1, 2022 /PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics
4y agoPKIPerkinElmer Board Declares Quarterly DividendBusiness WireThe Board of Directors of PerkinElmer, Inc. (NYSE:PKI) today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 10, 2023 to all shareholders of record at the
4y agoPKIPerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter OutlookBusiness WirePerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced it will release its full third quarter 2022 financial results on November 8, 2022. Management will host a
4y agoPKIPerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in GhanaBusiness WirePerkinElmer contributes reliable, fast, and cost-efficient solutions to screen for the disease in collaboration with the Sickle Cell Foundation and Ghana Health Services PerkinElmer Inc., a global leader committed to
4y agoPKIPerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and ManufacturingBusiness WireCellaca® PLX Image Cytometer redefines workflows, addresses multiple Critical Quality Attributes PerkinElmer, Inc., (NYSE:PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a
4y agoPKIPerkinElmer's Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis DetectionBusiness WireT-Cell Select reagent kit simplifies the T-SPOT.TB test laboratory workflow through automation expanding access to the most sensitive latent TB test on the market PerkinElmer's (NYSE:PKI) Oxford Immunotec today announced the U.S. Food and Drug Admini
4y agoPKIPerkinElmer to Present at Upcoming Investor ConferencesBusiness WirePerkinElmer Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 2022 Wells Fargo Healthcare Conference and the Baird's 2022 Global Healthcare Conference. 2022 Wells Farg
4y agoMRNA PKIJames Mock Joins Moderna as Chief Financial OfficerACCESS NewswireCAMBRIDGE, MA / ACCESSWIRE / August 17, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that James Mock has been appointed as Moderna's Chief Financial Officer, beginn
4y agoPKIPerkinElmer Announces Finance Leadership TransitionBusiness WireMax Krakowiak appointed new chief financial officer, replacing Jamey Mock PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Senior Vice President and Chief Financial Officer Jamey Mock w
4y agoCVS COST DASH PKI+3Jim Cramer says these 7 Covid-era winning stocks have staying powerCNBCJim Cramer named 7 stocks that were Covid-era winners and continue to perform well.
4y ago9866-HK AMD GPN CHKP+7Stocks making the biggest moves midday: PerkinElmer, Boeing, Global Payments, Bumble and moreCNBCThese are the stocks posting the largest moves in midday trading.
4y agoBA NIO CHKP BABA+6Stocks making the biggest moves in the premarket: Boeing, Nio, Check Point Software and moreCNBCThe stocks making the biggest moves in premarket trading include Boeing, Nio, Check Point Software, and more.
4y agoPKINew Mountain Capital Announces Intent to Acquire PerkinElmer's Applied, Food and Enterprise Services Businesses for up to $2.45 BillionBusiness WireNew Mountain Capital, a growth-oriented investment firm with over $37 billion in assets under management, today announced that it has entered into a definitive agreement with the intention to acquire PerkinElmer's Applied, Food and Enterprise Services b
4y agoPKIPerkinElmer Announces Financial Results for the Second Quarter of 2022Business WireSigns agreement with the intention to divest Applied, Food, and Enterprise Services businesses Second quarter revenue of $1.23 billion; 0% reported growth, 8% non-COVID organic growth Second quarter GAAP EPS from continuing operations of $1.42;
4y agoPKIPerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics CompanyBusiness WireEnters agreement with intention to divest Applied, Food and Enterprise Services businesses PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced it has entered into an agreement with the intentio
4y agoPKIPerkinElmer Board Declares Quarterly DividendBusiness WireThe Board of Directors of PerkinElmer, Inc. (NYSE:PKI) today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 11, 2022 to all shareholders of record at the close of business on October 21, 20
4y agoPKIPerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of DirectorsBusiness WirePerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Dr. Michelle McMurry-Heath has been elected to its board of directors, effective July 22, 2022. "I am pleased to welcome Michelle to Per
4y agoPKIPerkinElmer Schedules Earnings Call for Thursday, August 4, 2022Business WirePerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its second quarter 2022 financial results on Thursday, August 4, 2022 at 6:00 a.m. ET. The Company will host a con
4y agoPKIPerkinElmer Introduces Next Generation, Automated Gas Chromatography PlatformBusiness WireGC 2400 solution streamlines performance and delivers superior precision for high throughput environments PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today launched the GC 2400™ Platform, an advanced
4y agoPKIPerkinElmer Launches BioQule NGS System to Automate Library PreparationBusiness WireAffordable, easy-to-use benchtop system empowers labs of all sizes to both generate and quality control NGS libraries for genomic analysis PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced th
4y agoPKIPerkinElmer Announces Financial Results for the First Quarter of 2022Business WireFirst quarter revenue of $1.26 billion First quarter GAAP EPS from continuing operations of $1.40; Adjusted EPS of $2.41 Initiates Second Quarter and Raises Full Year Guidance PerkinElmer, Inc. (NYSE:PKI), a global leader committed to inn
4y agoPKIPerkinElmer Board Declares Quarterly DividendBusiness WireThe Board of Directors of PerkinElmer, Inc. (NYSE:PKI) today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 12, 2022 to all shareholders of record at the close of business on July 22, 2022.
4y agoPKIPerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022Business WirePerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its first quarter 2022 financial results after market close on Tuesday, May 3, 2022. The Company will host a confe
4y agoPKIPerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging SystemBusiness WireLaunches first-of-its-kind automated ultrasound platform to accelerate preclinical research PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio wi
4y agoPKIPerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and QuantificationBusiness WireNew high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to
4y agoPKIPerkinElmer to Present at Upcoming Investor ConferencesBusiness WirePerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen 42nd Annual Health Care Conference and the Barclays Global Healthcare Conference. Cowen 42nd Annua
4y agoPKIPerkinElmer to Present at Citi's 2022 Virtual Healthcare ConferenceBusiness WirePerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Citi's 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 8:45 a.m. ET. Prahlad Singh, pre
4y agoPKIU.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue VirusBusiness WireEUROIMMUN assay used to detect previous dengue virus infection will help children and adolescents gain access to vaccine EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG